Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recalled Device Costs, Test Payments Focus In OIG Work Plan

Executive Summary

The Health & Human Services’ watchdog branch plans to look at a spike in recall costs; Medicare’s progress in implementing lab-test payment reforms; and an ongoing review of FDA’s work on device cybersecurity issues.

You may also be interested in...

OIG Cardiac Implant Review Finds $1.5bn In Medicare Payments For Failed, Recalled Devices

Medicare was billed $1.5bn, and beneficiaries paid $140 million in copayments, for procedures associated with replacing seven models of defective or failed cardiac implants, according to preliminary results from an ongoing review by the US Department of Health and Human Services’ Office of Inspector General. The "early alert" from OIG’s investigation blamed a lack of device identifiers on claims forms for masking device performance data.

Labs Get Extra Year To Adjust To Diagnostics Reimbursement Revamp

CMS issued a long-awaited final rule that will establish a new market-based approach to setting lab-test payment rates. The Medicare agency was convinced to delay implementation by one year, to 2018, and to make other tweaks to its policy that industry stakeholders say will make the system more accurate.

HHS Watchdog Will Scrutinize FDA's Handle On Device Network Security

HHS’s Office of the Inspector General will examine FDA oversight of networked medical devices used in hospitals. The office’s work plan also includes scrutiny of Medicare payments for replacement devices, power mobility devices, orthotic braces and more.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts